Answers are grounded in this paper and cite their sources.
New N-substituted hydrazine linkers were synthesized and their hydrazone derivatives of adriamycin were prepared. These functionalized adriamycin derivatives were conjugated with a monoclonal antibody, 5E9. The release rate of adriamycin from the hydrazones and from some of the conjugates was studied, and their relationship to the IC50's of the conjugate against 5E9-positive Daudi cells was investigated.
No takes yet. Share an insight, caveat, or question.
Kaneko et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: